Erela Dana
Erela Dana BSc, MPhil, is the Director of Neurology and Immunology at GlobalData based in London. Erela has extensive disease area analysis and forecasting experience coupled with a wide breadth of therapy area expertise drawing from her previous roles. Erela has over 10 years’ experience in pharma, biotech, and medical device industries both in-house and in consulting. Her industry experience includes EMA product launching as well as integration of strategic multichannel marketing plans, specializing particularly on novel biologic products including immunotherapies. As part of her prior consultancy engagements, Erela has worked on numerous projects at GlobalData as a principal consultant as well as during her time at IQVIA Financial Institution Consulting, Align Strategy, and Informa Pharma Consulting focusing on commercial due diligences, market opportunity assessments and new product planning, and investment strategies, including transactional advisory provided to investment professionals. Erela holds a master’s degree (MPhil) in Bioscience Enterprise from University of Cambridge and a BSc in Biomedical Engineering from Johns Hopkins University.
Manasi Vaidya
Manasi Vaidya MA, is an editor for GlobalData Insights where she leads the journalist team’s forward-looking exclusive coverage on clinical research and drug development. She has reported on the healthcare industry in US and India for over 12 years, and prior to joining GlobalData, has published articles in Nature Medicine, MIT’s Technology Review India, Nautilus and more. She writes and edits features that look at the research, regulation and reimbursement of drugs with a focus on topics at the intersection of business and science. She has a Master of Arts degree from the Science, Health and Environmental Reporting program at New York University, and a Master of Technology degree in Biotechnology from Padmashree Dr. D. Y. Patil University.
Tatiana Kolesnikova